Telo Genomics Corp. (TSXV:TELO)

Canada · Delayed Price · Currency is CAD

0.0450

0.00 (0.00%)

Nov 4, 2026, 2:54 PM EST

Telo Genomics Financials Overview

Financials in millions CAD. Fiscal year is July - June.

Millions CAD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Income	-2.19	-2.19	-2.7	-2.72	-2.82	-2.11
Net Income	-2.31	-2.31	-2.72	-2.71	-2.82	-2.11
Earnings Per Share	-0.02	-0.02	-0.03	-0.04	-0.05	-0.04
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Investments	0.34	0.34	0.79	0.8	2.67	2.69
Total Debt	1.44	1.44	-	-	0.03	0.04
Net Cash (Debt)	-1.11	-1.11	0.79	0.8	2.64	2.65
Net Cash Growth	-	-	-0.84%	-69.86%	-0.46%	-26.24%
Net Cash Per Share	-0.01	-0.01	0.01	0.01	0.04	0.05

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Cash Flow	-1.59	-1.59	-2.33	-2.46	-2.63	-1.79
Capital Expenditures	-0.02	-0.02	-0	-0.01	-0.07	-0.03
Free Cash Flow	-1.61	-1.61	-2.33	-2.46	-2.7	-1.82
Free Cash Flow Growth	-	-	-	-	-	-

Valuation

Selected indicators aren't available for this stock.